Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels
The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.
Abstract
Objective To evaluate the efficacy and efficiency of weight-adjusted threshold levels for 17-hydroxyprogesterone (17-OHP) in screening newborn infants for 21 hydroxylase deficiency-congenital adrenal hyperplasia (21-OH-D-CAH).Design Analysis of the number of false-positive reports and diagnoses in infants, of 21-OH-D-CAH with the use of two strategies. Before October 1993, separate criteria for definite abnormal 17-OHP levels were established and implemented for 41,846 infants on the basis of birth weight: either less than 2200 gm (17-OHP level, 90 ng/ml) or 2200 gm or more (40 ng/ml). To reduce the burden of follow-up testing in low birth weight infants, criteria for definite abnormal 17-OHP results were statistically determined for four, rather than two, birth weight divisions: 1299 gm or less (17-OHP level > or = 165 ng/ml), 1300 to 1600 gm (> or = 135 ng/ml), 1700 to 2200 gm (> or = 90 ng/ml), and more than 2200 gm (> or = 40 ng/ml). These criteria were applied to the next 149,684 infants screened, and rates of false-positive test results and of false-positive diagnoses of 21-OH-D-CAH were compared.Results Before implementation of four-tiered weight-adjusted 17-OHP criteria, 205 definite abnormal reports yielded four confirmed cases of 21-OH-D-CAH (positive predictive value = 2%; incidence of 21-OH-D-CAH = 1 in 10,461). With the revised criteria, 61 of 149,684 infants had definite abnormal results and 14 cases of 21-OH-D-CAH were confirmed (positive predictive value, 20%; incidence of 21-OH-D-CAH, 1 in 10,692). No undetected severe cases of 21-OH-D-CAH have been subsequently reported.Conclusions Weight-adjusted criteria for 17-OHP levels in screening for 21 -OH-D-CAH markedly reduced the number of false-positive results requiring immediate follow-up testing, particularly among low birth weight infants. Increased specificity afforded by these criteria was not accompanied by diminished sensitivity in detecting severe cases. Long-term follow-up of this screened cohort will determine whether the goals of newborn screening for 21-OH-D-CAH are adequately and efficiently fulfilled by this approach.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are no universally accepted standards for stratifying infants, but most laboratories use a series of birth weight-adjusted cut-offs (65-67).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [65]
Citations
Cites
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Pang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293
Pang, S., Wallace, M. A., Hofman, L. F., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · PEDIATRICS · doi:10.1542/peds.81.6.866 · Cited by 191
Molecular and clinical advances in congenital adrenal hyperplasia
Miller, W. L., & Levine, L. S. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80334-7 · Cited by 178
Pang, S., Clark, A., Neto, E. C., Giugliani, R., Dean, H., Winter, J., Dhondt, J.-L., Farriaux, J. P., Graters, A., Cacciari, E., et al. (1993) · Screening · doi:10.1016/0925-6164(93)90024-d · Cited by 161
A Pilot Newborn Screening for Congenital Adrenal Hyperplasia in Alaska*
Pang, S., Murphey, W. H., Levine, L. S., SPENCE, D. A., Leon, A. E., LAFRANCHI, S. H., SURVE, A. S., & New, M. I. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-3-413 · Cited by 157
Newborn screening for congenital adrenal hyperplasia in New Zealand
Cutfield, W. S., & WEBSTER, D. R. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70513-9 · Cited by 77
Pang, S., & Clark, A. C. (1990) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(90)90068-e · Cited by 58
Delayed Diagnosis in Congenital Adrenal Hyperplasia: Need for Newborn Screening
Lebovitz, R. M. (1984) · American Journal of Diseases of Children · doi:10.1001/archpedi.1984.02140440055014 · Cited by 56
Research works printed but not linked: 2
- Allen, 1994, Salt-wasting 21-hydroxylase deficiency detected by newborn screening in a nonvirilized female, Pediatr Res, 35, 544
- Allen, 1995, Improved precision of newborn screening for 21-hydroxylase deficiency congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels, Pediatr Res, 37, 84A
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Metadata
- Authors
- Allen, D. B., Hoffman, G. L., Fitzpatrick, P., Laessig, R., Maby, S., & Slyper, A.
- Affiliations
- Children's Hospital of Wisconsin (US)
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 1997-01
- Volume
- 130
- Issue
- 1
- Pages
- 128-133
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2083269962
- Cited by
- 153
- References
- 11
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 7 · 2014: 2 · 2013: 8 · 2012: 9
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, newborn screening, 17-hydroxyprogesterone, false positives, positive predictive value, low birth weight infants, screening accuracy, cost-effectiveness of screening
- MeSH terms
- Adrenal Hyperplasia, Congenital, Body Weight, False Positive Reactions, Humans, Infant, Low Birth Weight, Infant, Newborn, Neonatal Screening, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. https://app.cochat.ai/papers/10.1016/s0022-3476(97)70321-4
- The paper
- Allen, D. B., Hoffman, G. L., Fitzpatrick, P., Laessig, R., Maby, S., & Slyper, A. (1997). Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. The Journal of Pediatrics. https://doi.org/10.1016/s0022-3476(97)70321-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.